Cargando…

Mixed Cryoglobulinaemia Vasculitis Treated with Obinutuzumab in a Patient Allergic to Rituximab

Cryoglobulinaemia is defined as the presence of cryoglobulins in the serum, which are immunoglobulins that reversibly precipitate and form a gel when the temperature is <37ºC. Autoimmune diseases such as Sjogren’s syndrome, systemic lupus erythematosus and rheumatoid arthritis could be associated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gaudêncio, Margarida, Parente, Catarina, Lameiras, Ana Catarina, Marinho, António
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SMC Media Srl 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668003/ https://www.ncbi.nlm.nih.gov/pubmed/34912747 http://dx.doi.org/10.12890/2021_003019

Ejemplares similares

Successful Treatment of Cryoglobulinaemia with Rituximab
por: Choudhry, M., et al.
Publicado: (2012)

AZD-1222/tozinameran: Flares of mixed cryoglobulinaemia vasculitis: 6 case reports
Publicado: (2022)

An interesting rash: leucocytoclastic vasculitis with type 2 cryoglobulinaemia
por: Mannu, Gurdeep Singh
Publicado: (2010)

Mixed cryoglobulinaemia vasculitis after sustained hepatitis C virological response with direct-acting antivirals
por: Barbieri, Diego, et al.
Publicado: (2018)

Obinutuzumab Rescue in Rituximab Resistant Mixed Cryoglobulinemia
por: Genest, Dominique S., et al.
Publicado: (2021)

A Case of Cutaneous Vasculitis with Underlying Hepatitis C and Cryoglobulinaemia
por: Groves, Cheryl, et al.
Publicado: (2008)

Bilateral retinal vasculitis associated with cold agglutinin disease treated with obinutuzumab and infliximab
por: Than, Ngoc Trong Tuong, et al.
Publicado: (2022)

GALLIUM trial: the tortoise (rituximab) and the hare (obinutuzumab) race
por: García-Muñoz, Ricardo, et al.
Publicado: (2019)

54. Type I cryoglobulinaemia: vascular occlusion and thrombosis
por: Zacharias, Hannah, et al.
Publicado: (2018)

Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders
por: Schieber, Timothy, et al.
Publicado: (2023)

Cost-effectiveness of obinutuzumab versus rituximab biosimilars for previously untreated follicular lymphoma
por: Spencer, Scott J, et al.
Publicado: (2021)

PB2549: CO-EXISTENT COLD AGGLUTININ DISEASE AND CRYOGLOBULINAEMIA
por: Japzon, Nicole, et al.
Publicado: (2023)

Predictive factors of renal involvement in cryoglobulinaemia: a retrospective study of 153 patients
por: Coliche, Vladimir, et al.
Publicado: (2018)

Rituximab and obinutuzumab differentially hijack the B cell receptor and NOTCH1 signaling pathways
por: Edelmann, Jennifer, et al.
Publicado: (2021)

Anti-tumor activity of obinutuzumab and rituximab in a follicular lymphoma 3D model
por: Decaup, E, et al.
Publicado: (2013)

Biochemical and biophysical characterization of purified native CD20 alone and in complex with rituximab and obinutuzumab
por: Agez, Morgane, et al.
Publicado: (2019)

Obinutuzumab/rituximab: Decreased platelet count and chronic COVID-19 pneumonia: case report
Publicado: (2020)

Comparative analysis of rituximab or obinutuzumab combined with CHOP in first-line treatment of follicular lymphoma
por: Claustre, Gwladys, et al.
Publicado: (2022)

Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab
por: Franceschini, Erica, et al.
Publicado: (2023)

Immunochemotherapy and Maintenance With Obinutuzumab or Rituximab in Patients With Previously Untreated Marginal Zone Lymphoma in the Randomized GALLIUM Trial
por: Herold, Michael, et al.
Publicado: (2022)

Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience
por: Lauletta, Gianfranco, et al.
Publicado: (2017)

Cryoglobulinaemia in Egyptian Patients with Extrahepatic Cutaneous Manifestations of Chronic Hepatitis C Virus Infection
por: Hegab, Doaa Salah, et al.
Publicado: (2015)

Disparity in peripheral and renal B-cell depletion with rituximab in systemic lupus erythematosus: an opportunity for obinutuzumab?
por: Reddy, Venkat R, et al.
Publicado: (2021)

Obinutuzumab in connective tissue diseases after former rituximab-non-response: a case series
por: Kvacskay, Peter, et al.
Publicado: (2022)

Fibrillary comma-shaped electron-dense organized glomerular deposits associated with cryoglobulinaemia
por: Stabellini, Nevio, et al.
Publicado: (2008)

Tixagevimab and Cilgavimab (Evusheld) in Rituximab-treated Antineutrophil Cytoplasmic Antibody Vasculitis Patients
por: Aqeel, Faten, et al.
Publicado: (2022)

Rituximab for Sjögren syndrome–associated type II mixed cryoglobulinemic cerebral vasculitis
por: Lioger, Bertrand, et al.
Publicado: (2016)

Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples
por: Reddy, Venkat, et al.
Publicado: (2017)

Pharmacokinetics, exposure, efficacy and safety of obinutuzumab in rituximab‐refractory follicular lymphoma patients in the GADOLIN phase III study
por: Gibiansky, Ekaterina, et al.
Publicado: (2019)

Obinutuzumab is Effective in Chronic Lymphocytic Leukemia and Rheumatoid Arthritis After Rituximab Failure: A Case Report
por: Lachowiez, Curtis, et al.
Publicado: (2017)

Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM Study
por: Townsend, William, et al.
Publicado: (2023)

Clinical application of obinutuzumab for treating chronic lymphocytic leukemia
por: Luan, Chunyan, et al.
Publicado: (2019)

Rituximab-Associated Flare of Cryoglobulinemic Vasculitis
por: Sy-Go, Janina Paula T., et al.
Publicado: (2021)

Correction Notice: Immunochemotherapy and Maintenance With Obinutuzumab or Rituximab in Patients With Previously Untreated Marginal Zone Lymphoma in the Randomized GALLIUM Trial
Publicado: (2022)

Obinutuzumab, a potent anti–B-cell agent, for rituximab-unresponsive IgM anti-MAG neuropathy
por: Rakocevic, Goran, et al.
Publicado: (2018)

Membranous Nephropathy with Proteinase 3-ANCA-associated Vasculitis Successfully Treated with Rituximab
por: Yoshida, Shun, et al.
Publicado: (2020)

Monoclonal gammopathy of renal significance presenting with cryoglobulinaemia type I associated severe thrombotic microangiopathy
por: Hesius, Eva, et al.
Publicado: (2022)

Delayed surgical strategy for type A aortic dissection associated with acute hepatitis C cryoglobulinaemia
por: Ahmed-Issap, Amber, et al.
Publicado: (2022)

Direct-acting antiviral therapy improves kidney survival in hepatitis C virus-associated cryoglobulinaemia: the RENALCRYOGLOBULINEMIC study
por: Pérez de José, Ana, et al.
Publicado: (2020)

Tolerability of obinutuzumab therapy in patients with rituximab-relapsed/refractory B-cell malignancies - a retrospective single center cohort study
por: Pirich, Theo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_22vofeeekc8g00l0u8cvfrs9ic